Is CHFHF or MRK a better dividend investment in 2026?

CHFHF currently yields 17094.02% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: CHFHF offers higher current income.

What is the dividend yield difference between CHFHF and MRK?

CHFHF has a forward dividend yield of 17094.02% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 17091.26 percentage points.

Home › Compare › CHFHF vs MRK

CHFHF vs MRK: Dividend Comparison 2026

CHFHF yields 17094.02% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CHFHF wins by $448480.53M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CHFHF

● Live price

17094.02%

Share price

$0.01

Annual div

$2.00

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$448480.58M

Annual income

$35,081,332,972.06

Full CHFHF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — CHFHF vs MRK

📍 CHFHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CHFHF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CHFHF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CHFHF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CHFHF

Annual income on $10K today (after 15% tax)

$1,452,991.45/yr

After 10yr DRIP, annual income (after tax)

$29,819,133,026.25/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, CHFHF beats the other by $29,819,124,697.84/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CHFHF + MRK for your $10,000?

CHFHF: 50%MRK: 50%

100% MRK50/50100% CHFHF

Portfolio after 10yr

$224240.32M

Annual income

$17,540,671,385.10/yr

Blended yield

7.82%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CHFHF

No analyst data

Altman Z

3.4

Piotroski

3/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CHFHF buys

MRK buys

No recent congressional trades found for CHFHF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCHFHFMRK

Forward yield	17094.02% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	-50%	32.7% ✓
Portfolio after 10y	$448480.58M ✓	$56.8K
Annual income after 10y	$35,081,332,972.06 ✓	$9,798.13
Total dividends collected	$375301.42M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: CHFHF vs MRK ($10,000, DRIP)

Year	CHFHF Portfolio	CHFHF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$865,401	$854,700.85	$11,206	$366.19	+$854.2K → CHFHF
2	$35,489,477	$34,563,497.67	$12,650	$502.35	+$35.48M → CHFHF
3	$700,321,674	$662,347,933.68	$14,407	$694.19	+$700.31M → CHFHF
4	$6,856,941,363	$6,107,597,172.29	$16,585	$967.82	+$6856.92M → CHFHF
5	$35,280,985,673	$27,944,058,414.43	$19,342	$1,363.89	+$35280.97M → CHFHF
6	$104,937,767,873	$67,187,113,203.41	$22,913	$1,947.19	+$104937.74M → CHFHF
7	$205,665,443,685	$93,382,032,060.80	$27,662	$2,823.89	+$205665.42M → CHFHF
8	$305,584,261,635	$85,522,236,892.13	$34,159	$4,173.35	+$305584.23M → CHFHF
9	$386,354,440,961	$59,379,281,010.83	$43,337	$6,308.80	+$386354.40M → CHFHF
10	$448,480,584,800	$35,081,332,972.06	$56,776	$9,798.13	+$448480.53M → CHFHF

CHFHF vs MRK: Complete Analysis 2026

CHFHF — Stock

China Art Financial Holdings Limited, an investment holding company, operates as an art finance service provider in the People's Republic of China. The company operates through three segments: Art and Asset Pawn Business, Art and Asset Auction Business, and Art and Asset Sales Business. It provides pawn loan services secured by artworks and assets as collateral. The company's artwork collateral portfolio primarily includes zisha artworks, as well as paintings and calligraphies, and jewel artworks. It also offers online art auction services and agency services. The company was founded in 2004 and is headquartered in Yixing, the People's Republic of China. China Art Financial Holdings Limited is a subsidiary of Intelligenesis Investment Co., Ltd.

Full CHFHF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this CHFHF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CHFHF vs SCHD CHFHF vs JEPI CHFHF vs O CHFHF vs KO CHFHF vs MAIN CHFHF vs JNJ CHFHF vs ABBV CHFHF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.